Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
39,221,841
-
Share change
-
-1,361,877
-
Total reported value
-
$118,049,010
-
Put/Call ratio
-
15%
-
Price per share
-
$3.01
-
Number of holders
-
75
-
Value change
-
-$2,176,076
-
Number of buys
-
36
-
Number of sells
-
44
Institutional Holders of SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) as of Q2 2015
As of 30 Jun 2015 SUNESIS PHARMACEUTICALS INC - COM NEW (SNSS) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 39,221,841 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Visium Asset Management, LP, BAKER BROS. ADVISORS LP, GREAT POINT PARTNERS LLC, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BALYASNY ASSET MANAGEMENT LLC, and Ghost Tree Capital, LLC.
This table shows 75 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.